Last reviewed · How we verify

NCT00363935

Bariatric Dose-ranging Study With Dexmedetomidine

Withdrawn Phase 4 Last updated 16 January 2019
What this trial tests

Phase 4 trial testing Dexmedetomidine in Abdominal Surgery Patients. Withdrawn.

Timeline
1 January 2007
Primary endpoint
1 January 2007
1 January 2007

Quick facts

Lead sponsorUniversity of Texas Southwestern Medical Center
PhasePhase 4
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Start date1 January 2007
Primary completion1 January 2007
Estimated completion1 January 2007
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 18 to 70, any sex, with Abdominal Surgery Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After obtaining informed consent,80 morbidly obese ASA II-III patients undergoing laparoscopic bariatric surgery procedures would be randomly assigned to one of four study groups at UTSWMC at Dallas.Hemodynamic paarameters, recovery times, postoperative pain scores, the need for rescue analgesics and side effects will be recorded.The purpose of this study is to determine the optimal linfusion rate of dexmedetomidine for maintaining cardiovscular stability during general anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Abdominal Surgery Patients

Currently open trials in the same condition.

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00363935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing